Our goal is to increase the range of healthcare communications services that we can offer to commercial and medical affairs teams internationally, and with the financial and strategic support of the team at LDC we have been able to do just that. Our acquisition of 2e marks an important milestone in our growth strategy and we are now delivering integrated creative and medical communications solutions on a truly global scale.”Oliver Dennis, CEO
Jonathan Bell, head of LDC in the North West, added: “When we first partnered with the team at Fishawack in 2017 they had an ambition to expand their overseas footprint and a clear plan of how to get there. With a focus on partnering with businesses that not only enable them to deliver their market-leading services in new geographies, but whose values strongly align with their own, the team has been able to drive strong and sustainable growth. It has been a pleasure to support Oliver and the team on their journey so far and we’re aligned in supporting their vision for continued expansion worldwide.”
The deal is a further example of LDC’s support of buy-and-build growth strategies, which saw the firm back 25 UK and overseas acquisitions, with a combined enterprise value of £125million, across its portfolio in 2018.
KPMG and Addleshaw Goddard advised Fishawack on its acquisition of 2e. 2e’s advisors included Results International, Stoll Keenon Ogden PLLC and Clifton Larson Allen.